NIH/GEMS
This article was originally published in The Gray Sheet
Executive Summary
License for diffusion tensor magnetic resonance imaging (DT-MRI) technology is granted to GE Medical Systems. Invented by researchers at the National Institute of Child Health and Human Development, the technology "allows physicians and researchers to make detailed, three-dimensional maps of nerve pathways in the brain, heart muscle fibers, and other soft tissue," according to NIH. GEMS will manufacture and market the product, which is expected to increase understanding and diagnosis of such conditions as stroke, amyotrophic lateral sclerosis, multiple sclerosis, autism, attention deficit disorder and schizophrenia. DT-MRI "produces sophisticated images of soft tissues by measuring the three-dimensional random motion of water molecules," NIH explains...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.